Pharmacokinetic-pharmacodynamic modeling of atracurium in intensive care patients

Journal of Clinical Pharmacology

Volumn 41, Issue 1, 2001, Pages 44-50

  Farenc, Christine ^a   Lefrant, Jean Yves ^b   Audran, Michel ^a   Bressolle, Françoise ^a  

^a ERS 655 Du CNRS Fac de P   (France)

^b NÎMES UNIVERSITY HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ATRACURIUM;

ADULT; ADULT RESPIRATORY DISTRESS SYNDROME; AGED; ARTICLE; ARTIFICIAL VENTILATION; CLINICAL ARTICLE; DRUG BLOOD LEVEL; DRUG CLEARANCE; DRUG DISTRIBUTION; DRUG ELIMINATION; DRUG HALF LIFE; FEMALE; HUMAN; HYSTERESIS; INTENSIVE CARE; MALE; NEUROMUSCULAR BLOCKING; PHARMACODYNAMICS;

ADULT; AGED; AGED, 80 AND OVER; ATRACURIUM; CRITICAL ILLNESS; DRUG ADMINISTRATION SCHEDULE; HUMANS; INFUSIONS, INTRAVENOUS; ISOQUINOLINES; MIDDLE AGED; MODELS, BIOLOGICAL; NEUROMUSCULAR NONDEPOLARIZING AGENTS; RESPIRATION, ARTIFICIAL; RESPIRATORY DISTRESS SYNDROME, ADULT;

EID: 0034747795     PISSN: 00912700     EISSN: None     Source Type: Journal    
DOI: 10.1177/00912700122009827     Document Type: Article

References (28)

1. Use of sedating drugs and neuromuscular blocking agents in patients requiring mechanical ventilation for respiratory failure: A national survey
2. Pharmacokinetics of drugs used in critically ill adults
3. Pharmacokinetic considerations
4. Pharmacology of neuromuscular blocking agents in the intensive care unit
5. The use of neuromuscular blocking drugs in intensive care practice
6. The use of curare like agents in resuscitation
7. Changes in acetylcholine receptor number in muscle relaxants: An investigation on the molecular mechanism of prolonged paralysis
8. A comparison of cisatracurium (51W89) and atracurium by infusion in critically ill patients
9. Simultaneous modeling of pharmacokinetics and pharmacodynamics: Application to d-tubocurarine
10. Pharmacokinetics and pharmacodynamics of atracurium in infants and children
11. Pharmacokinetics and pharmacodynamics of atracurium in the elderly
12. Pharmacokinetics and pharmacodynamics of atracurium obtained with arterial and venous blood samples
13. Pharmacokinetics and pharmacodynamics of atracurium with and without previous suxamethonium administration
14. Effect of thermal injury on pharmacokinetics and pharmacodynamics of atracurium in humans
15. A new four-parameter threshold model for the plasma atracurium concentration-response relationship
16. A pharmacokinetic-pharmacodynamic model for a muscle relaxant: Atracurium
17. The American-European consensus conference on ARDS
18. Prolonged paralysis in intensive care unit patients after the use of neuromuscular blocking agents: A review of literature
19. Monitoring neuromuscular function in the intensive care unit
20. Persistent paralysis in critical ill patients after long-term administration of vecuronium
21. High-performance liquid chromatographic method for determination of atracurium and laudanosine in human plasma: Application to pharmacokinetics
22. Simultaneous modeling of pharmacokinetics and pharmacodynamics with nonparametric pharmacodynamic model
23. Pharmacokinetics of atracurium and laudanosine in intensive care patients with acute respiratory distress syndrome undergoing mechanical ventilation
24. Comparison of the infusion covery profiles of vecuronium and cisatracurium 51W89 in intensive care unit
25. Comparison of train-of-four and best clinical assessment during continuous paralysis
26. Clinical experience and plasma laudanosine concentrations during the infusion of atracurium in the intensive therapy unit
27. Atracurium resistance in a critically ill patient